» Articles » PMID: 34452372

Animal Coronavirus Diseases: Parallels with COVID-19 in Humans

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2021 Aug 28
PMID 34452372
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus in humans, has expanded globally over the past year. COVID-19 remains an important subject of intensive research owing to its huge impact on economic and public health globally. Based on historical archives, the first coronavirus-related disease recorded was possibly animal-related, a case of feline infectious peritonitis described as early as 1912. Despite over a century of documented coronaviruses in animals, the global animal industry still suffers from outbreaks. Knowledge and experience handling animal coronaviruses provide a valuable tool to complement our understanding of the ongoing COVID-19 pandemic. In this review, we present an overview of coronaviruses, clinical signs, COVID-19 in animals, genome organization and recombination, immunopathogenesis, transmission, viral shedding, diagnosis, treatment, and prevention. By drawing parallels between COVID-19 in animals and humans, we provide perspectives on the pathophysiological mechanisms by which coronaviruses cause diseases in both animals and humans, providing a critical basis for the development of effective vaccines and therapeutics against these deadly viruses.

Citing Articles

The territorialization of Severe Acute Respiratory Syndrome and its socioeconomic, demographic and public health policy risk factors in Belém, state of Pará, Eastern Amazon, Brazil: a cross-sectional and ecological study.

Goncalves N, Leal A, Guimaraes H, Bernardes A, Brito S, Alves T PLoS One. 2025; 20(3):e0318607.

PMID: 40073047 PMC: 11902080. DOI: 10.1371/journal.pone.0318607.


Overview of the Trending Enteric Viruses and Their Pathogenesis in Intestinal Epithelial Cell Infection.

Chio C, Chien J, Chan H, Huang H Biomedicines. 2025; 12(12.

PMID: 39767680 PMC: 11672972. DOI: 10.3390/biomedicines12122773.


Epithelial barrier dysfunction and associated diseases in companion animals: Differences and similarities between humans and animals and research needs.

Ardicli S, Ardicli O, Yazici D, Pat Y, Babayev H, Xiong P Allergy. 2024; 79(12):3238-3268.

PMID: 39417247 PMC: 11657079. DOI: 10.1111/all.16343.


Design and Application of Biosafe Coronavirus Engineering Systems without Virulence.

Wu G, Li Q, Dai J, Mao G, Ma Y Viruses. 2024; 16(5).

PMID: 38793541 PMC: 11126016. DOI: 10.3390/v16050659.


Implementation of point-of-care platforms for rapid detection of porcine circovirus type 2.

Ke C, Du M, Hsieh W, Lin C, Ting J, Chiou M J Vet Sci. 2024; 25(2):e28.

PMID: 38568829 PMC: 10990909. DOI: 10.4142/jvs.23323.


References
1.
Herrewegh A, Smeenk I, Horzinek M, Rottier P, de Groot R . Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol. 1998; 72(5):4508-14. PMC: 109693. DOI: 10.1128/JVI.72.5.4508-4514.1998. View

2.
Doki T, Takano T, Kawagoe K, Kito A, Hohdatsu T . Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis. Res Vet Sci. 2016; 104:17-23. PMC: 7111801. DOI: 10.1016/j.rvsc.2015.11.005. View

3.
Sheikh A, McMenamin J, Taylor B, Robertson C . SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. Lancet. 2021; 397(10293):2461-2462. PMC: 8201647. DOI: 10.1016/S0140-6736(21)01358-1. View

4.
Pedersen N, Perron M, Bannasch M, Montgomery E, Murakami E, Liepnieks M . Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg. 2019; 21(4):271-281. PMC: 6435921. DOI: 10.1177/1098612X19825701. View

5.
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View